Compositions that treat or inhibit pathological conditions associated with inflammatory response
View Patent ↗A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
1. A method of preserving the health of joint tissues in a mammal comprising administering to the mammal a composition comprising tetrahydro-isohumulone, a component selected from the group consisting of oleanolic acid and ursolic acid, and a component selected from the group consisting of rosemary, and an extract of rosemary.
2. The method according to claim 1 , wherein the tetrahydro-isohumulone has a structure according to formula:
wherein R′ is carbonyl, and wherein R″ is CH 2 CH(CH 3 ) 2 .
3. The method of claim 1 , wherein the composition further comprises glucosamine or chondroitin sulfate.
4. A method of preserving the health of joint tissues in a mammal comprising administering to the mammal a composition comprising tetrahydro-isocohumulone, a component selected from group consisting of oleanolic acid and ursolic acid, and a component selected from the group consisting of rosemary, and an extract of rosemary.
5. The method according to claim 4 , wherein the tetrahydro-isocohumulone has a structure according to formula:
wherein R′ is carbonyl, and wherein R″ is CH(CH 3 ) 2 .
6. The method of claim 4 , wherein the composition further comprises glucosamine or chondroitin sulfate.
7. A method of preserving the health of joint tissues in a mammal comprising administering to the mammal a composition comprising tetrahydro-isoadhumulone, a component selected from group consisting of oleanolic acid and ursolic acid, and a component selected from the group consisting of rosemary, and an extract of rosemary.
8. The method according to claim 7 , wherein the tetrahydro-isoadhumulone has a structure according to formula:
wherein R′ is carbonyl, and wherein R″ is CH(CH 3 )CH 2 CH 3 .
9. The method of claim 7 , wherein the composition further comprises glucosamine or chondroitin sulfate.